Jiawei Geng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jiawei Geng has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Wenxue Wang
Department of Infectious Disease and Hepatic Disease, The First People's Hospital of Yunnan Province, the Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.
10 shared publications Ling Zhu
Department of Infectious Disease and Hepatic Disease, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China
5 shared publicationsHuijie Zhong
Department of Infectious Disease and Hepatic Disease, The First People’s Hospital of Yunnan Province
4 shared publicationsRuyi Zhang
Department of Infectious Disease and Hepatic Disease, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China
4 shared publicationsWei Yue
Department of Infectious Disease and Hepatic Disease, First People's Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China
4 shared publicationsZhongjian Liu
Institute of Basic and Clinical Medicine, First People’s Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China
4 shared publications
Latest Publications
- Open Access
- 22 June 2026
- Published by Springer Nature in Clinical and Experimental Medicine
Identification of circadian rhythm-associated key genes in metabolic dysfunction-associated fatty liver disease
As of now, current studies have confirmed that circadian rhythm genes (CRGs) can modulate the onset and development of metabolic dysfunction-associated fatty liver disease (MAFLD). Leveraging computational biology methodologies, systematic and thorough investigations into MAFLD and CRGs enhance our capacity to gain deeper insights into the disease's pathogenic mechanisms. MAFLD-associated datasets (GSE89632 and GSE126848) and 248 circadian rhythm genes genes (CRGs) were analyzed. Principal component analysis (PCA) was performed on the GSE89632 dataset, and samples were divided into training and test sets. Differentially expressed genes (DEGs) from the training set were intersected with key module genes from WGCNA to identify intersection genes. These were then analyzed for expression consistency across datasets, followed by machine learning to identify key genes. Further analyses, including nomogram development, gene set enrichment analysis (GSEA), immune infiltration, and drug prediction, were also conducted. Four outliers were excluded, leaving 17 MAFLD and 22 control samples for analysis. 141 intersection genes were identified, with 36 showing consistent expression trends. Machine learning identified SOCS2, FBXO27, and HMMR as key genes. A nomogram based on these genes predicted MAFLD patient survival. GSEA revealed significant enrichment in pathways like olfactory transduction and peroxisome. Mast cell activation correlated strongly with SOCS2 and FBXO27. SOCS2, FBXO27, and HMMR are identified as key genes in MAFLD, providing new insights into the disease mechanisms.
- 22 June 2026
- Published by Springer Nature in Clinical and Experimental Medicine
Open AccessIdentification of circadian rhythm-associated key genes in metabolic dysfunction-associated fatty liver disease
As of now, current studies have confirmed that circadian rhythm genes (CRGs) can modulate the onset and development of metabolic dysfunction-associated fatty liver disease (MAFLD). Leveraging computational biology methodologies, systematic and thorough investigations into MAFLD and CRGs enhance our capacity to gain deeper insights into the disease's pathogenic mechanisms. MAFLD-associated datasets (GSE89632 and GSE126848) and 248 circadian rhythm genes genes (CRGs) were analyzed. Principal component analysis (PCA) was performed on the GSE89632 dataset, and samples were divided into training and test sets. Differentially expressed genes (DEGs) from the training set were intersected with key module genes from WGCNA to identify intersection genes. These were then analyzed for expression consistency across datasets, followed by machine learning to identify key genes. Further analyses, including nomogram development, gene set enrichment analysis (GSEA), immune infiltration, and drug prediction, were also conducted. Four outliers were excluded, leaving 17 MAFLD and 22 control samples for analysis. 141 intersection genes were identified, with 36 showing consistent expression trends. Machine learning identified SOCS2, FBXO27, and HMMR as key genes. A nomogram based on these genes predicted MAFLD patient survival. GSEA revealed significant enrichment in pathways like olfactory transduction and peroxisome. Mast cell activation correlated strongly with SOCS2 and FBXO27. SOCS2, FBXO27, and HMMR are identified as key genes in MAFLD, providing new insights into the disease mechanisms.
- Open Access
- 27 April 2026
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 000 (000) , 000
Bile Drainage Improves Survival in Amatoxin-induced Severe Liver Injury: A Prospective Pilot Cohort Study
Amatoxin-containing mushroom poisoning causes fatal acute liver failure with >50% mortality despite maximal medical therapy. Interrupting the enterohepatic recirculation of amatoxins is a mechanistically rational but unproven therapeutic strategy. This study aimed to evaluate the efficacy and safety of biliary drainage (BD) in patients with pre-liver failure caused by amatoxin-containing mushroom poisoning.
- 27 April 2026
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 000 (000) , 000
Open AccessBile Drainage Improves Survival in Amatoxin-induced Severe Liver Injury: A Prospective Pilot Cohort Study
Amatoxin-containing mushroom poisoning causes fatal acute liver failure with >50% mortality despite maximal medical therapy. Interrupting the enterohepatic recirculation of amatoxins is a mechanistically rational but unproven therapeutic strategy. This study aimed to evaluate the efficacy and safety of biliary drainage (BD) in patients with pre-liver failure caused by amatoxin-containing mushroom poisoning.
- Open Access
- 21 April 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1752125
Multiple pulmonary cavities as the prominent manifestation of diffuse large B-cell lymphoma: a case report
A 60-year-old man complaining of fever, lacking in strength and with poor appetite for half month, was admitted to our Department of Infectious Diseases and Hepatic Diseases. The patient’s chest computed tomography revealed multiple cavities in the lungs. And he was diagnosed with diffuse large B‐cell lymphoma following the positron emission tomography–computed tomography scan and laparoscopic lymph node biopsy. His symptoms and the pulmonary cavity lesions improved significant after eight cycles of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy.
- 21 April 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1752125
Open AccessMultiple pulmonary cavities as the prominent manifestation of diffuse large B-cell lymphoma: a case report
A 60-year-old man complaining of fever, lacking in strength and with poor appetite for half month, was admitted to our Department of Infectious Diseases and Hepatic Diseases. The patient’s chest computed tomography revealed multiple cavities in the lungs. And he was diagnosed with diffuse large B‐cell lymphoma following the positron emission tomography–computed tomography scan and laparoscopic lymph node biopsy. His symptoms and the pulmonary cavity lesions improved significant after eight cycles of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy.
- Open Access
- 14 March 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
When cough leads to infarction: systemic arterial embolism as a sentinel complication of insidious pulmonary mucormycosis in an immunocompetent patient
Pulmonary mucormycosis is a rapidly progressive and often fatal invasive fungal infection typically associated with immunocompromised states. However, its
- 14 March 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Open AccessWhen cough leads to infarction: systemic arterial embolism as a sentinel complication of insidious pulmonary mucormycosis in an immunocompetent patient
Pulmonary mucormycosis is a rapidly progressive and often fatal invasive fungal infection typically associated with immunocompromised states. However, its
- Open Access
- 23 February 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Etiological landscape and co-infection dynamics in Acute Respiratory Infections (ARIs): insights from a multicenter outpatient study in Yunnan, China
ARIs pose significant health risks, especially among children, elderly, and immunocompromised populations. This study investigated the etiological spectrum
- 23 February 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessEtiological landscape and co-infection dynamics in Acute Respiratory Infections (ARIs): insights from a multicenter outpatient study in Yunnan, China
ARIs pose significant health risks, especially among children, elderly, and immunocompromised populations. This study investigated the etiological spectrum
- Open Access
- 27 January 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1735727
Enteric nervous system in microbiota-associated gut inflammation
The enteric nervous system (ENS), a distinctive and intricate compartment of the peripheral nervous system (PNS), is characterized by its capacity to autonomously coordinate fundamental gut functions independent of central nervous system (CNS) input. Comprising vast, densely packed networks of neurons and glial cells distributed throughout the intestinal wall, the ENS not only directly governs motility, secretion, and absorption but also engages in dynamic crosstalk with intestinal immune cells to establish immune defense barriers and fine-tune inflammatory responses. This system is persistently exposed to and deeply engaged with a dynamic microenvironment shaped by both external (e.g., microbiota and their metabolites) and internal (e.g., immune cells, stromal cells) signals. The gut microbiota and its metabolic products play pivotal roles in maintaining mucosal barrier integrity and orchestrating the progression of intestinal inflammation. They influence the development and repair of enteric neurons and can directly participate in disease pathogenesis or exert their effects through immune-mediated mechanisms. This review delves into the complex interplay between the ENS and the gut microbiota within the context of intestinal inflammation pathogenesis.
- 27 January 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1735727
Open AccessEnteric nervous system in microbiota-associated gut inflammation
The enteric nervous system (ENS), a distinctive and intricate compartment of the peripheral nervous system (PNS), is characterized by its capacity to autonomously coordinate fundamental gut functions independent of central nervous system (CNS) input. Comprising vast, densely packed networks of neurons and glial cells distributed throughout the intestinal wall, the ENS not only directly governs motility, secretion, and absorption but also engages in dynamic crosstalk with intestinal immune cells to establish immune defense barriers and fine-tune inflammatory responses. This system is persistently exposed to and deeply engaged with a dynamic microenvironment shaped by both external (e.g., microbiota and their metabolites) and internal (e.g., immune cells, stromal cells) signals. The gut microbiota and its metabolic products play pivotal roles in maintaining mucosal barrier integrity and orchestrating the progression of intestinal inflammation. They influence the development and repair of enteric neurons and can directly participate in disease pathogenesis or exert their effects through immune-mediated mechanisms. This review delves into the complex interplay between the ENS and the gut microbiota within the context of intestinal inflammation pathogenesis.
- Open Access
- 3 December 2024
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 63 (1) , 63-64
From coma to recovery: removal of amanitin by percutaneous transhepatic bile drainage in severe Amanita subjunquillea mushroom poisoning
- 3 December 2024
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 63 (1) , 63-64
Open AccessFrom coma to recovery: removal of amanitin by percutaneous transhepatic bile drainage in severe Amanita subjunquillea mushroom poisoning
- Open Access
- 17 September 2024
- Published by American Society for Microbiology in mSystems
- Vol. 9 (9) , e0088724
Microbial genotoxin-elicited host DNA mutations related to mitochondrial dysfunction, a momentous contributor for colorectal carcinogenesis
Gut microbe dysbiosis increases repetitive inflammatory responses, leading to an increase in the incidence of colorectal cancer. Recent studies have revealed that specific microbial species directly instigate mutations in the host nucleus DNA, thereby accelerating the progression of colorectal cancer. Given the well-established role of mitochondrial dysfunction in promoting colorectal cancer, it is reasonable to postulate that gut microbes may induce mitochondrial gene mutations, thereby inducing mitochondrial dysfunction. In this review, we focus on gut microbial genotoxins and their known and potential targets in mitochondrial genes. Consequently, we propose that targeted disruption of genotoxin transport pathways may effectively reduce the rate of mitochondrial gene mutations and yield substantial benefits for the prevention of colorectal carcinogenesis.
- 17 September 2024
- Published by American Society for Microbiology in mSystems
- Vol. 9 (9) , e0088724
Open AccessMicrobial genotoxin-elicited host DNA mutations related to mitochondrial dysfunction, a momentous contributor for colorectal carcinogenesis
Gut microbe dysbiosis increases repetitive inflammatory responses, leading to an increase in the incidence of colorectal cancer. Recent studies have revealed that specific microbial species directly instigate mutations in the host nucleus DNA, thereby accelerating the progression of colorectal cancer. Given the well-established role of mitochondrial dysfunction in promoting colorectal cancer, it is reasonable to postulate that gut microbes may induce mitochondrial gene mutations, thereby inducing mitochondrial dysfunction. In this review, we focus on gut microbial genotoxins and their known and potential targets in mitochondrial genes. Consequently, we propose that targeted disruption of genotoxin transport pathways may effectively reduce the rate of mitochondrial gene mutations and yield substantial benefits for the prevention of colorectal carcinogenesis.
- Open Access
- 26 January 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1288256
Gut microbes in central nervous system development and related disorders
The association between gut microbiota and central nervous system (CNS) development has garnered significant research attention in recent years. Evidence suggests bidirectional communication between the CNS and gut microbiota through the brain-gut axis. As a long and complex process, CNS development is highly susceptible to both endogenous and exogenous factors. The gut microbiota impacts the CNS by regulating neurogenesis, myelination, glial cell function, synaptic pruning, and blood-brain barrier permeability, with implication in various CNS disorders. This review outlines the relationship between gut microbiota and stages of CNS development (prenatal and postnatal), emphasizing the integral role of gut microbes. Furthermore, the review explores the implications of gut microbiota in neurodevelopmental disorders, such as autism spectrum disorder, Rett syndrome, and Angelman syndrome, offering insights into early detection, prompt intervention, and innovative treatments.
- 26 January 2024
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1288256
Open AccessGut microbes in central nervous system development and related disorders
The association between gut microbiota and central nervous system (CNS) development has garnered significant research attention in recent years. Evidence suggests bidirectional communication between the CNS and gut microbiota through the brain-gut axis. As a long and complex process, CNS development is highly susceptible to both endogenous and exogenous factors. The gut microbiota impacts the CNS by regulating neurogenesis, myelination, glial cell function, synaptic pruning, and blood-brain barrier permeability, with implication in various CNS disorders. This review outlines the relationship between gut microbiota and stages of CNS development (prenatal and postnatal), emphasizing the integral role of gut microbes. Furthermore, the review explores the implications of gut microbiota in neurodevelopmental disorders, such as autism spectrum disorder, Rett syndrome, and Angelman syndrome, offering insights into early detection, prompt intervention, and innovative treatments.